SCHEMBL25515757

SCHEMBL25515757

CCCCCC/C(=N\OC(C)=O)C(=O)c1ccc2c(c1)c1cc(C(=O)c3ccc(OC(C)=O)cc3)ccc1n2-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.43
PTGS2 P35354 1/20 0.41
ELANE P08246 3/20 0.40
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
THRB P10828 2/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ESR1 P03372 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515746 0.95 CNR2 (0.38) CNR2PTGS2ELANESMN1; SMN2NPSR1
SCHEMBL23801780 0.88 CNR2 (0.43) CNR2PTGS2ELANEMAPTSMN1; SMN2
SCHEMBL23801788 0.88 CNR2 (0.43) CNR2PTGS2ELANEMAPTSMN1; SMN2
SCHEMBL13541267 0.85 CNR2 (0.53) CNR2MAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL13925254 0.85 CNR2 (0.53) CNR2MAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL23801742 0.84 CNR2 (0.42) CNR2ELANEMAPTSMN1; SMN2MEN1
SCHEMBL23802410 0.84 CNR2 (0.41) CNR2PTGS2MAPTSMN1; SMN2ALDH1A1
SCHEMBL23802446 0.84 CNR2 (0.46) CNR2NPC1
SCHEMBL23801783 0.82 CNR2 (0.41) CNR2ELANEMAPTSMN1; SMN2MEN1
SCHEMBL23801343 0.82 CNR2 (0.44) CNR2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 CNR2 663/4885PTGS2 1837/4885ELANE 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.